Systematic Review of CT and MR Perfusion Imaging for Assessment of Acute Cerebrovascular Disease

References

1. ↵
   Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Medical Decision Making 1991;11:88–94

   Abstract/FREE Full Text
2. ↵
   Sunshine JL, Bambakidis N, Tarr RW, et al. Benefits of perfusion MR imaging relative to diffusion MR imaging in the diagnosis and treatment of hyperacute stroke. AJNR Am J Neuroradiol 2001;22:915–21

   Abstract/FREE Full Text
3. ↵
   Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508–17

   CrossRefPubMedWeb of Science
4. Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299–309

   CrossRefPubMedWeb of Science
5. ↵
   Lev MH, Segal AZ, Farkas J, et al. Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis: prediction of final infarct volume and clinical outcome. Stroke 2001;32:2021–28

   Abstract/FREE Full Text
6. ↵
   Wintermark M, Reichhart M, Thiran J-P, et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 2002;51:417–32

   CrossRefPubMedWeb of Science
7. ↵
   Chalela JA, Alsop DC, Gonzalez-Atavales JB, et al. Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke 2000;31:680–87

   Abstract/FREE Full Text
8. ↵
   Derex L, Nighoghossian N, Hermier M, et al. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator. J Neurol Sci 2004;225:3–9

   CrossRefPubMedWeb of Science
9. ↵
   Furlan AJ, Eyding D, Albers GW, et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227–31

   Abstract/FREE Full Text
10. ↵
    Hacke W, Albers G, Al-Rawi Y, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66–73

    Abstract/FREE Full Text
11. ↵
    Kluytmans M, van Everdingen KJ, Kappelle LJ, et al. Prognostic value of perfusion- and diffusion-weighted MR imaging in first 3 days of stroke. European Radiol 2000;10:1434–41

    CrossRef
12. Perkiö J, Soinne L, Ostergaard L, et al. Abnormal intravoxel cerebral blood flow heterogeneity in human ischemic stroke determined by dynamic susceptibility contrast magnetic resonance imaging. Stroke 2005;36:44–49

    Abstract/FREE Full Text
13. ↵
    Warach S, Dashe JF, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab 1996;16:53–59

    CrossRefPubMedWeb of Science
14. ↵
    Warach S, Pettigrew LC, Dashe JF, et al. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. Ann Neurol 2000;48:713–22

    CrossRefPubMedWeb of Science
15. ↵
    Schellinger PD, Jansen O, Fiebach JB, et al. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke 2000;31:1318–28

    Abstract/FREE Full Text
16. ↵
    Arenillas JF, Rovira A, Molina CA, et al. Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke. Stroke 2002;33:2197–203

    Abstract/FREE Full Text
17. ↵
    Barber PA, Parsons MW, Desmond PM, et al. The use of PWI and DWI measures in the design of “proof-of-concept” stroke trials. J Neuroimaging 2004;14:123–32

    CrossRefPubMed
18. ↵
    Bruening R, Dichgans M, Berchtenbreiter C, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: decrease in regional cerebral blood volume in hyperintense subcortical lesions inversely correlates with disability and cognitive performance. AJNR Am J Neuroradiol 2001;22:1268–74

    Abstract/FREE Full Text
19. ↵
    Hermier M, Nighoghossian N, Adeleine P, et al. Early magnetic resonance imaging prediction of arterial recanalization and late infarct volume in acute carotid artery stroke. J Cereb Blood Flow Metab 2003;23:240–48

    PubMedWeb of Science
20. ↵
    Hillis AE, Wityk RJ, Beauchamp NJ, et al. Perfusion-weighted MRI as a marker of response to treatment in acute and subacute stroke. Neuroradiology 2004;46:31–39

    CrossRefPubMedWeb of Science
21. ↵
    Hillis AE, Wityk RJ, Tuffiash E, et al. Hypoperfusion of Wernicke's area predicts severity of semantic deficit in acute stroke. Ann Neurol 2001;50:561–66

    CrossRefPubMedWeb of Science
22. ↵
    Liu Y, Karonen JO, Vanninen RL, et al. Acute ischemic stroke: predictive value of 2D phase-contrast MR angiography—serial study with combined diffusion and perfusion MR imaging. Radiology 2004;231:517–27

    PubMedWeb of Science
23. ↵
    Nighoghossian N, Hermier M, Adeleine P, et al. Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator. Stroke 2003;34:458–63

    Abstract/FREE Full Text
24. ↵
    Parsons MW, Barber PA, Chalk J, et al. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 2002;51:28–37

    CrossRefPubMedWeb of Science
25. ↵
    Rohl L, Geday J, Ostergaard L, et al. Correlation between diffusion- and perfusion-weighted MRI and neurological deficit measured by the Scandinavian Stroke Scale and Barthel Index in hyperacute subcortical stroke (< or = 6 hours). Cerebrovasc Dis 2001;12:203–13

    CrossRefPubMed
26. ↵
    Singer OC, Du Mesnil De Rochemont R, Foerch C, et al. Early functional recovery and the fate of the diffusion/perfusion mismatch in patients with proximal middle cerebral artery occlusion. Cerebrovasc Dis 2004;17:13–20

    CrossRefPubMedWeb of Science
27. ↵
    Uno M, Harada M, Yoneda K, et al. Can diffusion- and perfusion-weighted magnetic resonance imaging evaluate the efficacy of acute thrombolysis in patients with internal carotid artery or middle cerebral artery occlusion? Neurosurgery 2002;50:28–34

    CrossRefPubMed
28. ↵
    Yamada M, Yoshimura S, Kaku Y, et al. Prediction of neurologic deterioration in patients with lacunar infarction in the territory of the lenticulostriate artery using perfusion CT. AJNR Am J Neuroradiol 2004;25:402–08

    Abstract/FREE Full Text
29. ↵
    Alsop DC, Makovetskaya E, Kumar S, et al. Markedly reduced apparent blood volume on bolus contrast magnetic resonance imaging as a predictor of hemorrhage after thrombolytic therapy for acute ischemic stroke. Stroke 2005;36:746–50

    Abstract/FREE Full Text
30. Eastwood JD, Lev MH, Azhari T, et al. CT perfusion scanning with deconvolution analysis: pilot study in patients with acute middle cerebral artery stroke. Radiology 2002;222:227–36

    PubMedWeb of Science
31. Kim EY, Na DG, Kim SS, et al. Prediction of hemorrhagic transformation in acute ischemic stroke: role of diffusion-weighted imaging and early parenchymal enhancement. AJNR Am J Neuroradiol 2005;26:1050–55

    Abstract/FREE Full Text
32. Murphy BD, Fox AJ, Lee DH, et al. Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurements. Stroke 2006;37:1771–77

    Abstract/FREE Full Text
33. Schaefer PW, Ozsunar Y, He J, et al. Assessing tissue viability with MR diffusion and perfusion imaging. AJNR Am J Neuroradiol 2003;24:436–43

    Abstract/FREE Full Text
34. Schaefer PW, Roccatagliata L, Ledezma C, et al. First-pass quantitative CT perfusion identifies thresholds for salvageable penumbra in acute stroke patients treated with intra-arterial therapy. AJNR Am J Neuroradiol 2006;27:20–25

    Abstract/FREE Full Text
35. Tan JC, Dillon WP, Liu S, et al. Systematic comparison of perfusion-CT and CT-angiography in acute stroke patients. Ann Neurol 2007;61:533–43

    CrossRefPubMedWeb of Science
36. Wintermark M, Flanders AE, Velthuis B, et al. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 2006;37:979–85

    Abstract/FREE Full Text
37. Wu O, Christensen S, Hjort N, et al. Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using MRI. Brain 2006;129:2384–93

    Abstract/FREE Full Text
38. Butcher K, Parsons M, Baird T, et al. Perfusion thresholds in acute stroke thrombolysis. Stroke 2003;34:2159–64

    Abstract/FREE Full Text
39. Schramm P, Schellinger PD, Klotz E, et al. Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of less than 6 hours’ duration. Stroke 2004;35:1652–58

    Abstract/FREE Full Text
40. Thomalla GJ, Kucinski T, Schoder V, et al. Prediction of malignant middle cerebral artery infarction by early perfusion- and diffusion-weighted magnetic resonance imaging. Stroke 2003;34:1892–99

    Abstract/FREE Full Text
41. Fiehler J, von Bezold M, Kucinski T, et al. Cerebral blood flow predicts lesion growth in acute stroke patients. Stroke 2002;33:2421–25

    Abstract/FREE Full Text
42. Grandin CB, Duprez TP, Smith AM, et al. Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. Radiology 2002;223:361–70

    CrossRefPubMed
43. Schaefer PW, Hunter GJ, He J, et al. Predicting cerebral ischemic infarct volume with diffusion and perfusion MR imaging. AJNR Am J Neuroradiol 2002;23:1785–94

    Abstract/FREE Full Text
44. ↵
    Shih LC, Saver JL, Alger JR, et al. Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke 2003;34:1425–30

    Abstract/FREE Full Text
45. ↵
    Lee S-K, Kim DI, Jeong E-K, et al. Postoperative evaluation of Moyamoya disease with perfusion-weighted MR imaging: initial experience. AJNR Am J Neuroradiol 2003;24:741–47

    Abstract/FREE Full Text
46. ↵
    Marks MP, Tong DC, Beaulieu C, et al. Evaluation of early reperfusion and I.V. tPA therapy using diffusion- and perfusion-weighted MRI. Neurology 1999;52:1792–98

    Abstract/FREE Full Text
47. ↵
    Allder SJ, Moody AR, Martel AL, et al. Differences in the diagnostic accuracy of acute stroke clinical subtypes defined by multimodal magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2003;74:886–88

    Abstract/FREE Full Text
48. Gerraty RP, Parsons MW, Barber PA, et al. Examining the lacunar hypothesis with diffusion and perfusion magnetic resonance imaging. Stroke 2002;33:2019–24

    Abstract/FREE Full Text
49. Kim JH, Shin T, Park JH, et al. Various patterns of perfusion-weighted MR imaging and MR angiographic findings in hyperacute ischemic stroke. AJNR Am J Neuroradiol 1999;20:613–20

    Abstract/FREE Full Text
50. Liu Y, Karonen JO, Vanninen RL, et al. Detecting the subregion proceeding to infarction in hypoperfused cerebral tissue: a study with diffusion and perfusion weighted MRI. Neuroradiology 2003;45:345–51

    CrossRefPubMed
51. Liu Y, Laakso MP, Karonen JO, et al. Apolipoprotein E polymorphism and acute ischemic stroke: a diffusion- and perfusion-weighted magnetic resonance imaging study. J Cereb Blood Flow Metab 2002;22:1336–42

    CrossRefPubMedWeb of Science
52. ↵
    Liu Y-J, Chen C-Y, Chung H-W, et al. Neuronal damage after ischemic injury in the middle cerebral arterial territory: deep watershed versus territorial infarction at MR perfusion and spectroscopic imaging. Radiology 2003;229:366–74

    CrossRefPubMed
53. ↵
    Fiehler J, Knudsen K, Kucinski T, et al. Predictors of apparent diffusion coefficient normalization in stroke patients. Stroke 2004;35:514–19

    Abstract/FREE Full Text
54. ↵
    Sunshine JL, Tarr RW, Lanzieri CF, et al. Hyperacute stroke: ultrafast MR imaging to triage patients prior to therapy. Radiology 1999;212:325–32

    PubMedWeb of Science
55. ↵
    Karonen JO, Vanninen RL, Liu Y, et al. Combined diffusion and perfusion MRI with correlation to single-photon emission CT in acute ischemic stroke. Ischemic penumbra predicts infarct growth. Stroke 1999;30:1583–90

    Abstract/FREE Full Text
56. ↵
    Na DG, Ryoo JW, Lee KH, et al. Multiphasic perfusion computed tomography in hyperacute ischemic stroke: comparison with diffusion and perfusion magnetic resonance imaging. J Comput Assist Tomogr 2003;27:194–206

    CrossRefPubMed
57. ↵
    Ribo M, Molina CA, Rovira A, et al. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke 2005;36:602–06

    Abstract/FREE Full Text
58. ↵
    Finnigan SP, Rose SE, Walsh M, et al. Correlation of quantitative EEG in acute ischemic stroke with 30-day NIHSS score: comparison with diffusion and perfusion MRI. Stroke 2004;35:899–903

    Abstract/FREE Full Text
59. Hillis AE, Wityk RJ, Barker PB, et al. Change in perfusion in acute nondominant hemisphere stroke may be better estimated by tests of hemispatial neglect than by the National Institutes of Health Stroke Scale. Stroke 2003;34:2392–96

    Abstract/FREE Full Text
60. ↵
    Neumann-Haefelin T, du Mesnil de Rochemont R, Fiebach JB, et al. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke 2004;35:109–14

    Abstract/FREE Full Text